Article info

Multiplex immunohistochemistry/immunofluorescence (mIHC/IF) for PD-L1 testing in triple-negative breast cancer: a translational assay compared with conventional IHC
Free

Authors

  1. Correspondence to Dr Joe Yeong, Pathology, Singapore General Hospital, Singapore 169856, Singapore; joe.yeong.p.s{at}sgh.com.sg; Professor Puay Hoon Tan; tan.puay.hoon{at}singhealth.com.sg
View Full Text

Citation

Yeong J, Tan T, Chow ZL, et al
Multiplex immunohistochemistry/immunofluorescence (mIHC/IF) for PD-L1 testing in triple-negative breast cancer: a translational assay compared with conventional IHC

Publication history

  • Received October 6, 2019
  • Revised December 23, 2019
  • Accepted December 31, 2019
  • First published January 22, 2020.
Online issue publication 
August 19, 2020

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.